Fund Holdings — Merck & Co., Inc.

Total Portfolio Value
$215.60M
Total Bought
$31.1K
Total Sold
$0
Net Transaction
+$31.1K
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
PERSONALIS INC(PSNL)14,044,94314,044,943049,29892,13542.73%+42,837
KYMERA THERAPEUTICS INC(KYMR)772,165772,165021,13433,69715.63%+12,563
EVAXION BIOTECH A/S1,214,1261,214,12602,2462,9751.38%+728
ALECTOR INC3,545,7193,545,71904,3614,9642.30%+603
SUTRO BIOPHARMA INC(STRO)2,723,5092,723,50901,7721,9440.90%+172
CARISMA THERAPEUTICS INC1,473,2401,473,24004575770.27%+120
LAVA THERAPEUTICS NV1,149,3451,149,34501,4601,5170.70%+57
VIRIDIAN THERAPEUTICS INC(VRDN)93,41493,41401,2591,3060.61%+47
TUHURA BIOSCIENCES(HURA)013,950+13,9500310.01%+31
NEUPHORIA THERAPEUTICS INC10,02710,027058710.03%+13
XILIO THERAPEUTICS INC(XLO)1,483,7581,483,75801,0751,0090.47%-66
MODERNA INC(MRNA)2,308,1902,308,190065,43763,68329.54%-1,754
ENTRADA THERAPEUTICS INC(TRDA)1,739,7681,739,768015,72811,6915.42%-4,036
Page 1 of 1